The use of inflammatory parameters, such as IL-6, tumor necrosis factor alpha (TNF-α), and CRP, allows for a simple and rapid evaluation of whether IF effectively reduces chronic inflammation—a factor known to be involved in the initiation and progression of cancers [32]. This evidence concerns the gene IL6 and cancer.